Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Oct 2023
Historique:
received: 24 08 2023
revised: 17 10 2023
accepted: 18 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

Melatonin is widely present in Nature. It has pleiotropic activities, in part mediated by interactions with high-affinity G-protein-coupled melatonin type 1 and 2 (MT1 and MT2) receptors or under extreme conditions, e.g., ischemia/reperfusion. In pharmacological concentrations, it is given to counteract the massive damage caused by MT1- and MT2-independent mechanisms. The aryl hydrocarbon receptor (AhR) is a perfect candidate for mediating the latter effects because melatonin has structural similarity to its natural ligands, including tryptophan metabolites and indolic compounds. Using a cell-based Human AhR Reporter Assay System, we demonstrated that melatonin and its indolic and kynuric metabolites act as agonists on the AhR with EC

Identifiants

pubmed: 37895177
pii: ijms242015496
doi: 10.3390/ijms242015496
pmc: PMC10607054
pii:
doi:

Substances chimiques

Ligands 0
Melatonin JL5DK93RCL
PPAR gamma 0
Receptors, Aryl Hydrocarbon 0
PPARG protein, human 0
AHR protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR071189
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073004
Pays : United States
Organisme : VA
ID : 1I01BX004293-01A1
Pays : United States
Organisme : BLRD VA
ID : I01 BX004293
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149267
Pays : United States

Références

Chem Biol Interact. 2002 Sep 20;141(1-2):3-24
pubmed: 12213382
J Med Chem. 2006 Oct 19;49(21):6177-96
pubmed: 17034125
Cell Mol Life Sci. 2014 Aug;71(16):2997-3025
pubmed: 24554058
FASEB J. 2014 Jul;28(7):2775-89
pubmed: 24668754
Exp Dermatol. 2015 Apr;24(4):245-51
pubmed: 25644500
Int J Mol Sci. 2018 Nov 28;19(12):
pubmed: 30487387
Exp Dermatol. 2017 Jul;26(7):563-568
pubmed: 27619234
Int J Mol Sci. 2014 Sep 09;15(9):15858-90
pubmed: 25207599
Biofactors. 2009 Mar-Apr;35(2):183-92
pubmed: 19449447
Annu Rev Pharmacol Toxicol. 2016;56:361-83
pubmed: 26514204
FEBS Lett. 1996 May 20;386(2-3):219-24
pubmed: 8647286
Nat Med. 2010 Apr;16(4):406-12
pubmed: 20348925
J Pineal Res. 2016 Nov;61(4):426-437
pubmed: 27600803
Int J Mol Sci. 2021 Jan 22;22(3):
pubmed: 33499346
J Invest Dermatol. 2011 Jan;131(1):203-10
pubmed: 20861855
Curr Top Med Chem. 2011;11(2):221-40
pubmed: 21244359
Int J Biol Macromol. 2022 Jun 1;209(Pt A):1111-1123
pubmed: 35421413
Int J Mol Sci. 2022 Feb 24;23(5):
pubmed: 35269623
J Dermatol Sci. 2017 Jan;85(1):36-43
pubmed: 27720465
FASEB J. 1998 Oct;12(13):1401-8
pubmed: 9761784
J Biochem Mol Toxicol. 2001;15(4):187-96
pubmed: 11673847
J Pineal Res. 2018 Sep;65(2):e12501
pubmed: 29702749
Pigment Cell Melanoma Res. 2008 Jun;21(3):388-96
pubmed: 18444964
J Pineal Res. 2016 Sep;61(2):187-97
pubmed: 27117941
Structure. 2021 Sep 2;29(9):940-950.e4
pubmed: 33713599
Endocr Rev. 2018 Dec 1;39(6):990-1028
pubmed: 30215696
Bioessays. 2016 Dec;38(12):1193-1194
pubmed: 27739090
Biochem Pharmacol. 2018 Sep;155:419-424
pubmed: 30055148
J Pineal Res. 2013 Mar;54(2):127-38
pubmed: 23137057
Trends Endocrinol Metab. 2008 Jan;19(1):17-24
pubmed: 18155917
Mol Cell Endocrinol. 2012 Apr 4;351(2):152-66
pubmed: 22245784
FASEB J. 2006 Jul;20(9):1564-6
pubmed: 16793870
J Pineal Res. 2016 Aug;61(1):27-40
pubmed: 27112772
Free Radic Biol Med. 2022 May 1;184:30-41
pubmed: 35367341
Annu Rev Pharmacol Toxicol. 2003;43:309-34
pubmed: 12540743
Genes Immun. 2020 May;21(3):150-168
pubmed: 32203088
Front Plant Sci. 2016 Feb 19;7:198
pubmed: 26925091
Front Endocrinol (Lausanne). 2019 Apr 17;10:249
pubmed: 31057485
Int J Mol Sci. 2022 Aug 26;23(17):
pubmed: 36077103
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3604-3613
pubmed: 30733286
Biochemistry. 2005 Jul 5;44(26):9300-7
pubmed: 15981996
Curr Opin Toxicol. 2017 Feb;2:87-92
pubmed: 32296737
Int J Mol Sci. 2022 Jan 22;23(3):
pubmed: 35163162
Mol Cell Biol. 2015 Jan;35(1):182-98
pubmed: 25332241
FASEB J. 2013 Jul;27(7):2742-55
pubmed: 23620527
J Dermatol Sci. 2015 Nov;80(2):83-8
pubmed: 26276439
Br J Pharmacol. 2014 Jan;171(1):186-201
pubmed: 24117008
Int J Mol Sci. 2014 Sep 30;15(10):17705-32
pubmed: 25272227
J Pineal Res. 2013 Apr;54(3):303-12
pubmed: 23110400
J Invest Dermatol. 2012 Jan;132(1):59-68
pubmed: 21753779
J Pineal Res. 2014 Aug;57(1):90-102
pubmed: 24867336
Cell Discov. 2022 Apr 26;8(1):37
pubmed: 35473936
Sci Rep. 2021 Apr 13;11(1):8002
pubmed: 33850196
Cell Mol Life Sci. 2017 Nov;74(21):3913-3925
pubmed: 28803347
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7997-E8006
pubmed: 28874589
Int J Mol Sci. 2018 Oct 08;19(10):
pubmed: 30297679
Curr Top Med Chem. 2002 Feb;2(2):181-97
pubmed: 11899100
Mini Rev Med Chem. 2013 Mar;13(3):373-84
pubmed: 23190034
Arch Dermatol Res. 2014 Nov;306(9):769-79
pubmed: 24966027
J Invest Dermatol. 2018 Mar;138(3):490-499
pubmed: 29428440
Cell Host Microbe. 2021 Aug 11;29(8):1235-1248.e8
pubmed: 34214492
Exp Dermatol. 2008 Sep;17(9):713-30
pubmed: 18643846
Expert Opin Ther Targets. 2016;20(3):303-17
pubmed: 26465080
Int J Tryptophan Res. 2017 Feb 16;10:1178646917691738
pubmed: 28469467
Sci Rep. 2015 Aug 03;5:12689
pubmed: 26235394
Nat Struct Mol Biol. 2008 Sep;15(9):893-5
pubmed: 18769464
Sci Rep. 2017 Apr 28;7(1):1274
pubmed: 28455491
Eur J Med Chem. 2022 Dec 15;244:114845
pubmed: 36274276
J Clin Invest. 1995 Aug;96(2):741-50
pubmed: 7635967
PLoS One. 2012;7(12):e52658
pubmed: 23285134
Trends Pharmacol Sci. 2015 Oct;36(10):688-704
pubmed: 26435213
Biochim Biophys Acta. 2007 Aug;1771(8):991-8
pubmed: 17400022
Int J Mol Sci. 2021 Aug 11;22(16):
pubmed: 34445339
J Biol Chem. 2004 Apr 2;279(14):14033-8
pubmed: 14722075
Br J Pharmacol. 2008 Jul;154(6):1182-95
pubmed: 18493248
J Biol Chem. 2000 Oct 6;275(40):31311-7
pubmed: 10913150
J Pineal Res. 2015 Oct;59(3):292-307
pubmed: 26201382
Sci Rep. 2022 Oct 5;12(1):16625
pubmed: 36198709
Nat Rev Immunol. 2019 Mar;19(3):184-197
pubmed: 30718831
J Biol Chem. 2001 Aug 24;276(34):31475-8
pubmed: 11425848
J Pineal Res. 2008 Nov;45(4):515-23
pubmed: 18717775
J Invest Dermatol. 2004 Aug;123(2):305-12
pubmed: 15245430
Antioxidants (Basel). 2021 Apr 17;10(4):
pubmed: 33920561

Auteurs

Andrzej T Slominski (AT)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Tae-Kang Kim (TK)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Radomir M Slominski (RM)

Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Department of Biomedical Informatics and Data Science, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Yuwei Song (Y)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Department of Biomedical Informatics and Data Science, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Shariq Qayyum (S)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Brigham's Women's Hospital, Harvard University, Boston, MA 02115, USA.

Wojciech Placha (W)

Department of Medicinal Biochemistry, Collegium Medicum, Jagiellonian University, 31-008 Kraków, Poland.

Zorica Janjetovic (Z)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Konrad Kleszczyński (K)

Department of Dermatology, University of Münster, Von-Esmarch-Str. 58, 48161 Münster, Germany.

Venkatram Atigadda (V)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Yuhua Song (Y)

Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Chander Raman (C)

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Cornelis J Elferink (CJ)

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 79567, USA.

Judith Varady Hobrath (JV)

Sygnature Discovery, Discovery Building, Biocity, Nottingham NG1 1GF, UK.

Anton M Jetten (AM)

Cell Biology Section, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, USA.

Russel J Reiter (RJ)

Department of Cell Systems and Anatomy, UT Health, Long School of Medicine, San Antonio, TX 78229, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH